382 related articles for article (PubMed ID: 12202993)
1. Tuberous sclerosis in a 19-week fetus: immunohistochemical and molecular study of hamartin and tuberin.
Wei J; Li P; Chiriboga L; Mizuguchi M; Yee H; Miller DC; Greco MA
Pediatr Dev Pathol; 2002; 5(5):448-64. PubMed ID: 12202993
[TBL] [Abstract][Full Text] [Related]
2. Hamartin and tuberin expression in human tissues.
Johnson MW; Kerfoot C; Bushnell T; Li M; Vinters HV
Mod Pathol; 2001 Mar; 14(3):202-10. PubMed ID: 11266527
[TBL] [Abstract][Full Text] [Related]
3. The expression of hamartin, the product of the TSC1 gene, in normal human tissues and in TSC1- and TSC2-linked angiomyolipomas.
Plank TL; Logginidou H; Klein-Szanto A; Henske EP
Mod Pathol; 1999 May; 12(5):539-45. PubMed ID: 10349994
[TBL] [Abstract][Full Text] [Related]
4. Tuberous sclerosis: immunohistochemistry expression of tuberin and hamartin in a 31-week gestational fetus.
Vinaitheerthan M; Wei J; Mizuguchi M; Greco A; Barness EG
Fetal Pediatr Pathol; 2004; 23(4):241-9. PubMed ID: 16095035
[TBL] [Abstract][Full Text] [Related]
5. Proteins interacting with the tuberous sclerosis gene products.
Rosner M; Freilinger A; Hengstschläger M
Amino Acids; 2004 Oct; 27(2):119-28. PubMed ID: 15351877
[TBL] [Abstract][Full Text] [Related]
6. Heterozygosity for the tuberous sclerosis complex (TSC) gene products results in increased astrocyte numbers and decreased p27-Kip1 expression in TSC2+/- cells.
Uhlmann EJ; Apicelli AJ; Baldwin RL; Burke SP; Bajenaru ML; Onda H; Kwiatkowski D; Gutmann DH
Oncogene; 2002 Jun; 21(25):4050-9. PubMed ID: 12037687
[TBL] [Abstract][Full Text] [Related]
7. The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination.
Benvenuto G; Li S; Brown SJ; Braverman R; Vass WC; Cheadle JP; Halley DJ; Sampson JR; Wienecke R; DeClue JE
Oncogene; 2000 Dec; 19(54):6306-16. PubMed ID: 11175345
[TBL] [Abstract][Full Text] [Related]
8. Developmental expression of the tuberous sclerosis proteins tuberin and hamartin.
Murthy V; Stemmer-Rachamimov AO; Haddad LA; Roy JE; Cutone AN; Beauchamp RL; Smith N; Louis DN; Ramesh V
Acta Neuropathol; 2001 Mar; 101(3):202-10. PubMed ID: 11307618
[TBL] [Abstract][Full Text] [Related]
9. Cardiac rhabdomyomas in tuberous sclerosis complex show apoptosis regulation and mTOR pathway abnormalities.
Kotulska K; Larysz-Brysz M; Grajkowska W; Jóźwiak J; Włodarski P; Sahin M; Lewin-Kowalik J; Domańska-Pakieła D; Jóźwiak S
Pediatr Dev Pathol; 2009; 12(2):89-95. PubMed ID: 17990907
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous loss of hamartin and tuberin from the cerebrum, kidney and heart with tuberous sclerosis.
Mizuguchi M; Ikeda K; Takashima S
Acta Neuropathol; 2000 May; 99(5):503-10. PubMed ID: 10805093
[TBL] [Abstract][Full Text] [Related]
11. Loss of expression of tuberin and hamartin in tuberous sclerosis complex-associated but not in sporadic angiofibromas.
Fackler I; DeClue JE; Rust H; Vu PA; Kutzner H; Rütten A; Kaddu S; Sander CA; Volkenandt M; Johnson MW; Vinters HV; Wienecke R
J Cutan Pathol; 2003 Mar; 30(3):174-7. PubMed ID: 12641776
[TBL] [Abstract][Full Text] [Related]
12. Analysis of TSC2 stop codon variants found in tuberous sclerosis patients.
Goedbloed MA; Nellist M; Verhaaf B; Reuser AJ; Lindhout D; Sunde L; Verhoef S; Halley DJ; van den Ouweland AM
Eur J Hum Genet; 2001 Nov; 9(11):823-8. PubMed ID: 11781698
[TBL] [Abstract][Full Text] [Related]
13. Tuberous sclerosis genes regulate cellular 14-3-3 protein levels.
Hengstschläger M; Rosner M; Fountoulakis M; Lubec G
Biochem Biophys Res Commun; 2003 Dec; 312(3):676-83. PubMed ID: 14680818
[TBL] [Abstract][Full Text] [Related]
14. Hamartin, the product of the tuberous sclerosis 1 (TSC1) gene, interacts with tuberin and appears to be localized to cytoplasmic vesicles.
Plank TL; Yeung RS; Henske EP
Cancer Res; 1998 Nov; 58(21):4766-70. PubMed ID: 9809973
[TBL] [Abstract][Full Text] [Related]
15. Tuberous sclerosis causing mutants of the TSC2 gene product affect proliferation and p27 expression.
Soucek T; Rosner M; Miloloza A; Kubista M; Cheadle JP; Sampson JR; Hengstschläger M
Oncogene; 2001 Aug; 20(35):4904-9. PubMed ID: 11521203
[TBL] [Abstract][Full Text] [Related]
16. Antisense suppression of TSC1 gene product, hamartin, enhances neurite outgrowth in NGF-treated PC12h cells.
Floricel F; Higaki K; Maki H; Nanba E; Ninomiya H; Ohno K
Brain Dev; 2007 Sep; 29(8):502-9. PubMed ID: 17376623
[TBL] [Abstract][Full Text] [Related]
17. Expression and prognostic value of tuberous sclerosis complex 2 gene product tuberin in human pancreatic cancer.
Kataoka K; Fujimoto K; Ito D; Koizumi M; Toyoda E; Mori T; Kami K; Doi R
Surgery; 2005 Sep; 138(3):450-5. PubMed ID: 16213898
[TBL] [Abstract][Full Text] [Related]
18. Dissociate expression of tuberous sclerosis complex 1 product hamartin in a skin and pulmonary lesion of a tuberous sclerosis complex.
Wataya-Kaneda M; Katayama I
Hum Pathol; 2009 Mar; 40(3):430-4. PubMed ID: 18835623
[TBL] [Abstract][Full Text] [Related]
19. Tuberin, the tuberous sclerosis complex 2 tumor suppressor gene product, regulates Rho activation, cell adhesion and migration.
Astrinidis A; Cash TP; Hunter DS; Walker CL; Chernoff J; Henske EP
Oncogene; 2002 Dec; 21(55):8470-6. PubMed ID: 12466966
[TBL] [Abstract][Full Text] [Related]
20. Tuberin and hamartin are aberrantly expressed and linked to clinical outcome in human breast cancer: the role of promoter methylation of TSC genes.
Jiang WG; Sampson J; Martin TA; Lee-Jones L; Watkins G; Douglas-Jones A; Mokbel K; Mansel RE
Eur J Cancer; 2005 Jul; 41(11):1628-36. PubMed ID: 15951164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]